throbber
Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA544380
`ESTTA Tracking number:
`06/21/2013
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`85518756
`OMEGA VALLEY FARMERS, LLC
`THE 3 OMEGAS
`JOSEPH S. HEINO
`DAVIS & KUELTHAU, S.C.
`111 E KILBOURN AVE STE 1400
`MILWAUKEE, WI 53202-6613
`UNITED STATES
`jheino@dkattorneys.com
`Appeal Brief
`11530809.PDF(357136 bytes )
`11530693.PDF(1631039 bytes )
`Patrick M. Bergin
`pbergin@dkattorneys.com
`/Patrick M. Bergin/
`06/21/2013
`
`Proceeding
`Applicant
`Applied for Mark
`Correspondence
`Address
`
`Submission
`Attachments
`
`Filer's Name
`Filer's e-mail
`Signature
`Date
`
`

`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE
`
`TRADEMARK TRIAL AND APPEAL BOARD
`
`In re Application of
`Agricultural Omega Solutions, LLC and
`Omega Valley Farmers, LLC
`
`Serial No. 85/518,756
`
`Filed: January 18,2012
`
`Trademark: THE 3 OMEGAS
`
`\-/‘-/\.2\./\.y\..g'\....r'\../‘-._-’
`
`\_/
`
`Trademark Trial and Appeal Board
`U.S. Patent and Trademark Office
`
`P.O. Box 1451
`
`Alexandria, VA 22313-1451
`
`Law Office 109
`
`Trademark Attorney:
`
`David Collier, Esq.
`
`APPLICANTS’ MAIN BRIEF
`
`UNDER TMBP § 1203.01
`
`Introduction
`
`Agricultural Omega Solutions, LLC and Omega Valley Farmers, LLC (“Applicants”) hereby
`
`appeal from the Examining Attorney's final refusal to register the above—identified mark dated
`
`October 24, 2012, and respectfully requests the Trademark Trial and Appeal Board (“TTAB") to
`
`reverse the Examining Attorney's decision.
`
`Applicants’ Trademark _
`
`Applicants seek registration on the Principal Register of their mark:
`
`THE 3 OMEGAS
`
`for “meat, namely, beef and pork; fish; poultry and game; eggs; and dairy products, namely,
`
`milk, buttermilk, non-alcoholic egg nog, half and half, whipping cream, yogurt, butter, sour
`
`cream, dry buttermilk powder, dry milk powder, cheese, cream cheese, and cottage cheese; all of
`
`the foregoing containing omega acids” in Int’l Class 29; for “ice cream, ice milk and frozen
`
`

`
`yogurt; flour; all of the foregoing containing omega acids” in Int’l Class 30; and for “animal feed
`
`containing omega acids” in Int’l Class 31 (‘‘Applicants’ Mark”).
`
`The Rejection
`
`The Examining Attorney refused registration of Applicant’s Mark contending that the mark
`
`as applied to the goods is “merely descriptive.” Office Action dated October 24, 2012.
`
`In that final Office Action, the Examining Attorney expounded his position contending the
`
`“there are three types of omega-3 fatty acids, specifically, ALA, EPA and DHA.” Indeed, the
`
`final Office Action is replete with references to the “omega-3” fatty acids and appears to be
`
`hopelessly entrenched with the notion that gng “omega-3” fatty acids are relevant and that there
`
`are “three types of omega-3” fatty acids. However, the final Office Action states, in part, the
`
`following:
`
`Furthermore, according to the applicant’s (sic) website, “Agricultural Omega
`Solutions LLC (AgO3) supports financially strong, farm supply co-ops located in the Med-
`West with its core services providing specialty custom feed supply. Technologies increase
`the Omega 3 fatty acid content of the targeted animals daily ration which increase the
`Omega 3 content of the animal products for human consmnption. The technology and
`application ofthe process naturally balance the Omega 6 to Omega 3 (emphasis added).
`
`Applicants respectfully submit that this is a tacit confirmation that the mark THE 3
`
`OMEGAS is not, and cannot be, referring in a limiting way to just omega-3 fatty acids, or to the
`
`“three types of omega-3 fatty acids,” because it also references omega—6 fatty acids.
`
`Applicants further submit that the world of fatty acids is not limited to omega-3 and omega-6
`
`fatty acids. Indeed, there are also omega-7 and omega-9 fatty acids, as evidenced by the attached
`
`Exhibits D, E and F.1 Each exhibit will be discussed in Applicants’ argument presented below.
`
`1 Exhibits A1-A37, B l -B 13 and Cl-C23 are already of record in this matter, those exhibits having been filed with
`Applicants’ response to the first Office Action.
`
`

`
`Argument
`
`1. Applicant’s Mark Is A Composite Mark That Must Be Considered In Its Entirety
`
`Applicants respectfully submit that the THE 3 OMEGAS mark is a “composite” mark.
`
`Accordingly, the Examining Attorney cannot depart from the rule that marks should be
`
`considered in their entireties and not improperly dissected. Colgate-Palmolive Co. v. Carter-
`
`Wallace, Inc. 167 U.S.P.Q. 272 (C.C.P.A. 1970). As the U.S. Supreme Court has stated: “The
`
`commercial impression of a trademark is derived from it as a whole, not from its elements
`
`separated and considered in detail.” Estate ofP. D. Beckwith, Inc. v. Commissioner 0fPatents,
`
`252U.S. 538, 545-46 (1920). Thus, it is the impression which the mark as a whole creates on the
`
`average reasonably prudent buyer and not the parts thereof which is important.
`
`In the first Office Action, dated May 1, 2013, identifiers were proposed by the Examining
`
`Attorney to add the phrase “. . .all of the aforementioned goods are made in significant part of
`
`omega acids (emphasis added).” In Applicants’ view, this identifier phrase went too far and was
`
`misleading. Accordingly, Applicants responded, instead, by adding the phrase “. . .all of the
`
`foregoing containing omega acids.”2
`
`Applicants then went one step further by disclaiming the word “OMEGA” apart from the
`
`mark as shown. Now, it is apparently the Examining Attorney's position that, because
`
`Applicants have disclaimed the descriptive word "OMEGA," the word “OMEGA” is the
`
`dominant portion of the mark sought to be registered and that it is the only word of the mark that
`
`is capable of distinguishing Applicants’ goods in commerce. Applicants respectfully traverse
`
`that position and the attempt to minimize the impact of the number “3” in the mark and the word
`“THE.” This position also overlooks the fact that the mark "THE 3 OMEGAS“ is a unitary term
`
`(which is a composite mark) and it is the unit which creates the commercial impression upon
`
`2 The proposed amended identifiers were subsequently accepted in the final Office Action.
`
`

`
`potential customers. Such customers neither know nor care Whether or not a part of a mark is
`
`disclaimed. Disclaimers have no effect upon purchasers. Purchasers do not know about
`
`"disclaimers," "dominant portions" or "distinguishing features." They are impressed by the mark
`
`as they see it or hear it, and they do not ordinarily stop to analyze it. Ex Parie Maya De Mexico,
`
`103 U.S.P.Q. (BNA) 158, 1954 WL 5556 (Comm'r Pat. & Trademarks 1954); Supply Mfg. Co. v.
`
`King Trimmings, Inc, 220 F. Supp. 947, 139 U.S.P.Q. (BNA) 163 (S.D. N.Y. 1963).
`
`2. The Applicants’ Mark, in its Entirety, does not Merely Describe Appiicants’ Goods
`
`To -be “merely” descriptive, the term must be “only” descriptive, i.e., the term serves no
`
`purpose-other than to describe the goods or services.
`
`In re Quick-Print Copy Shop, Inc., 205
`
`U.S.P.Q. 505 (C.C.P.A. 1980).
`
`If a mark suggests, however, a number of possible uses or
`
`characteristics of the goods or services, including one that is descriptive, the mark is not merely
`
`descriptive.
`
`In re National Tea Co., 144 U.S.P.Q. 286, 287 (T.T.A.B. 1965) (NO BONES
`
`ABOUT IT not merely descriptive of ham).
`
`There is but a thin line between the two types of marks (descriptive versus suggestive);
`
`where there is doubt whether a mark is descriptive or suggestive, that doubt should be resolved
`
`in favor of the applicant. In re Bel Paese Sales Co.,
`
`1 U.S.P.Q.2d 1233, 1986 WL 83304
`
`(T.T.A.B. 1986).
`
`Applicants’ Mark is, at most, suggestive of Applicants’ goods. While it may be Stated that the
`
`word “OMEGA” conveys characteristics of the goods, the number “3” placed in front of the
`
`word “OMEGA” and the word “THE” placed in front of the number “3,” is distinctive as applied
`
`to the goods, thus rendering the mark not descriptive, but suggestive.
`
`The final Office Action attempts to unduly narrow the mark to use with goods containing only
`
`omega-3 fatty acids. As stated earlier, both the first and the final Office Actions seem hopelessly
`
`entrenched in the notion that the goods with which the Applicants’ Mark is used relate only to
`
`

`
`omega-3 fatty acids. They are, however, not so limited. The final Office Action, as discussed
`
`earlier, acknowledges that omega-6 fatty acids are also involved Further, the fact that omega-6,
`
`omega—7 and omega-9 fatty acids are also known to the purchasing public undermines any notion
`
`of just “three” of anything.
`
`In view of “four” fatty acids, one cannot assume that omega-3 fatty
`
`acids are the only fatty acids concerned with the Applicants’ Mark.
`
`In “layman’s terms,” Exhibit D states as follows:
`
`Most of us have heard of omega-3 essential fatty acids, and maybe omega-6 essential
`fatty acids. There are also omega-9 fatty acids, which are not “essential,” that is, you don’t
`have to get them in your diet so you won’t die, and there is yet another group of useful but
`non-essential fatty acids known as the omega—7’s.
`
`In more technical terms, Exhibit E states, in relevant part, the following:3
`
`a methyl
`A fatty acid molecule is shaped like a caterpillar with two different ends:
`group and a water-soluble end that is the carboxyl end. There are different families of fat_ty
`acids in feed: omega-3, omega-6, omega-7 and omega-9. The most common numbering
`system is called the omega system. This system numbers carbon atoms in sequence,
`starting from the methyl end. The other commonly used system, called the delta (d)
`system, starts at the acid end and numbers the carbon atoms in reverse direction (emphasis
`added).
`
`Indeed, as pointed out above, Applicants specifically reference two of the four fatty acids on
`
`their website, namely omega-6 and omega-3 fatty acids.
`
`Lastly, Exhibit F discusses the balance needed for balancing omega-3 fatty acids with omega-
`
`6 and omega-9 fatty acids, thus reinforcing the notion that the world of omega-type fatty acids
`
`are not limited to omega-3 fatty acids or to the three types of omega-3 fatty acids.
`
`3. Many Registrations Containing the Word “OMEGA” Exist in the PTO’s TESS Records,
`Some Without Disclaimers of Just the Word “OMEGA,” in the Relevant Classes of Goods
`
`That Applicants’ Mark is suggestive and not descriptive is borne out by the many registrations
`
`that have been granted by the Trademark Office and many without a disclaimer of the word
`
`“OMEGA” in Int’l Classes 29, 30 and 3l.
`
`3 Noting in particular that Exhibit E is drawn to animal feed.
`
`

`
`A sample of active registrations is shown in the below charts (the charts also noting instances
`
` in which disclaimers of other wordin but not 'ust the word “OMEGA ” were re uired):
`
`
`
`DISCLAIMER
`
`“SKIM AND OMEGA-3 + COQ10”
`
`4
`
`4
`
`4.
`
`4‘
`
`44
`
`44
`
`4
`
`ALGAE
`
`4
`
`OMEGA 3
`
`EPA DHA OMEGA 3
`EPA DHA OMEGA 3
`
`EPA DHA OMEGA 3
`
`,,
`
`,,
`
`,,
`
`,,
`
`INT’L CLASS 029:
`
`
`
`
`
`Efifibit MARK/REGISTRATION NO.
`
`SKIM PLUS WITH OMEGA-3
`
`A1
`
`42
`
`43
`
`A4
`
`
`
`+C0Q10
`4,096,767
`
`ALGAE T0 OMEGA
`4,044,105
`
`WE BRING OMEGA-3 T0 LIFE
`3,944,270
`
`OMEGA 3 PLUS PARMALAT
`3,795,852
`
`EPA DHA OMEGA 3
`
`EPA DHA OMEGA 3
`
`3,803,340
`3,795,847
`
`EPA DHA OMEGA 3
`
`EPA DHA OMEGA 3
`
`347954846
`
`EPAX MARINE OMEGA-3
`
`A9
`
`“MARINE OMEGA-3 FORMULA”
`
`3,480,845
`
`OMEGA FARMS
`
`OMEGA FARMS
`
`3,283’I
`
`OMEGA
`
`“
`
`.‘
`
`,,
`
`,,
`
`OMEGA-3
`
`‘
`
`SMART BALANCE OMEGA
`
`“
`
`,,
`
`A4 5
`
`OMEGA BALANCE
`3,151,478
`
`
`
`
`
`
`
`
`

`
`
`
`
`
`
`
`
`
`DISCLAIMER
`
`
`
`“
`
`;.
`
`OMEGA 3 EGGS
`
`,,
`
`,,
`
`OMEGA 3 EGGS
`
`W054
`
`OMEGA BEEF
`
`
`
`
`
`Efifibit MARK/REGISTRATION N0.
`A16
`OMEGA NUTRITION
`2,962,682
`
`
`E‘§4E%‘X§‘ E?§i°é1?o?.%s‘¥é£’3L “PREMIUM CANOLA OIL WITH
`
`OMEGA 3, 6 & 9 CHOLESTEROL FREE
`
`CANOLA OIL PURE CANOLA
`
`
`
`’
`FREE 100% CANOLA OIL 1~2-3
`
`PURE CANOLA OIL
`
`3,911,696
`
`
`
`
`
`
`
`
`
`222%:sW
`M
`
`A27
`
`— EE
`
`A28
`
`
`
`OMEGA PLUS
`
`“
`
`,,
`
`OMEGA NUTRITION GARLIC-
`
`A31
`
`
`
`CHILI FLAX SEED OIL
`
`2,905,905
`
`OMEGA PROTEIN
`
`“NUTRITION GARLIC-CHILI FLAX
`
`SEED OIL”
`
`“PROTEIN”
`
`
`
`
`

`
`
`
`
`
`—_—
`
`
`
`
`
`OMEGA III1
`
`
`
`INT’L CLASS 030:
`
`
`
`
`
`
`MARK’REG‘STRA“°N N°-
`33§§3?3SL1MS
`
`“EPA DHA OMEGA 3” 2
`E1;‘33gI:*6‘ 0MEGA_
`
`
`
`Elgézggf OMEGA 3
`“EPADHA OMEGA 3”
`
`
`
`53‘333§15°MEGA3
`553533?
`
`
`
`
`
`
`
`33$3?°°AT
`
`OMEGA NUTRITION
`
`2,962,682
`
`3,562,824
`
`OMEGA NUTRITION
`
`“NUTRITION”
`
`2,139,963
`
`10
`
`11
`
`

`
`OMEGA
`"
`
`1,969,071
`
`
`
`OMEGA
`
`1,358,310
`
`INT’L CLASS 031:
`
`E’§';bi‘ MARK/REGISTRATION N0.
`C1
`OMEGA SEA
`4,093,104
`
`DISCLAIMER
`
`C2
`
`'
`
`OMEGA ONE
`4,093,054
`
`FIBREGIZED OMEGA
`
`,,
`
`,,
`
`.
`
`
`
`
`
`
`
`“O3 CHIA (SALVIA HISPANICA L.)
`PREMIUM RICH SOURCE OF OMEGA 3
`
`HIGH DIETARY FIBER HIGH PROTEIN
`
`
`
`LOW CARB PRODUCT OF MEXICO”
`
`and “NET WT. 10.6 OZ (300G)”
`
`O3 CHIA (SALVIA HISPANICA
`L.) PREMIUM RICH SOURCE OF
`OMEGA 3 HIGH DIETARY
`
`FIBER HIGH PROTEIN LOW
`
`CARB PRODUCT OF MEXICO
`AGROBECK INTERNATIONAL
`
`NET WT. 10.6 OZ (300G)
`4,030,688
`
`ALGAE TO OMEGA
`
`OMEGA 3 DRY THE OMEGA-3
`SOLUTION FOR DRY
`
`APPLICATION
`
`3,954,697
`
`OMEGA 3 DRY
`3,954,668
`
`~
`
`OMEGA MAX
`3,987,244
`
`OMEGA FIELDS
`3,157,683
`
`COOL OMEGA 40
`
`OMEGA MAINTENANCE
`3,268,034
`
`OMEGA NATURAL
`
`
`
`
`
`
`
`
`
`C8
`
`C9
`
`C1 1
`
`
`
`
`
`
`
`
`
`“
`
`,,
`
`“OMEGA 3 DRY” and “THE OMEGA-3
`SOLUTION FOR DRY APPLICATIO ”
`
`
`
`G,
`
`OMEGA 3 DRY
`
`,,
`
`,,
`
`,,
`
`
`
`9
`
`

`
`
`
`DISCLAIMER
`
`“
`
`G,
`
`OMEGA 3 DRY
`
`,,
`
`,,
`
`OMEGA
`
`“ A
`OMEGA
`
`,,
`
`“
`
`,,
`
`OMEGA
`
`
`
`“SKIN & COAT SYSTE ”
`
`
`
`“
`
`,,
`
`,,
`
`PROTEIN
`
`,,
`
`HEALTH
`
`“
`
`,,
`
`
`
`
`Exhibit
`P
`
`
`
`MARKIREGISTRATION NO.
`
`OMEGA 3 DRY
`358793113
`
`OMEGA NIBBLERS
`2,624,269
`
`OMEGA GRANDE
`2,555,809
`
`OMEGA HORSESHINE
`2,609,463
`
`OMEGA PRIDE
`2,664,456
`
`OMEGA PRIDE SKIN & COAT
`SYSTEM
`
`2,673,102
`
`OMEGA-PRO
`
`OMEGA PROTEIN
`2,796,615 1
`
`OMEGA HEALTH
`2,510,933
`
`OMEGA PET
`
`C13
`
`'Iz
`
`C14
`
`C15
`
`C16
`
`C1
`
`7
`
`C18
`
`C20
`
`C21
`
`C23
`
`
`
`“PORK PRODUCTS” and the “omega-3
`symbol”
`
`OMEGA-3 PORK PRODUCTS
`1,724,068
`
`TESS printouts of the above were attached as Exhibits A1-A37, B1-B13 and C1-C23 to
`
`App1icant’s Response filed October 1, 2012, which is part of the record of this appeal.
`
`The above third-party registrations show that the word “OMEGA" appearing in marks is not
`
`descriptive but suggestive, and that the PTO has acted accordingly.
`
`In each case, the mark was
`
`found to be registrable on the Principal Register.
`
`In the face of this evidence, it is difficult to
`
`reach any conclusion but that, as in these 73 registrations, the word “OMEGA” together with
`
`other words results in a mark is distinctive enough to qualify Applicants’ mark THE 3 OMEGAS
`
`for registration on the Principal Register.
`
`

`
`Further, those registrations for marks using the word “OMEGA” alone or in combination with
`
`other words as shown above, more than half of them in Int’l Classes 29 and 30 and more than
`
`two-thirds of them in Int’1 Class 31 did not require a disclaimer of the word “OMEGA” apart
`
`from the mark as shown.
`
`Lastly, Applicant notes that, in the final Office Action, the Examining Attorney comments on
`
`the content of Applicants’ website. Applicants again respectfully submit that the simple fact that
`
`the Examining Attorney needed to refer back to Applicants’ website for clarification of the mark
`
`is tacit confirmation that the Applicants’ Mark is not merely descriptive, but suggestive.
`
`4. The Attachments To The Final Office Action Are Replete With Information That Does
`
`Not Support The Basis For Rejection
`
`The final Office Action includes articles that are purported to show that Applicants’ Mark “is
`
`used descriptively in connection with_the goods/services.” Applicants respectfully disagree.
`
`It
`
`appears that, to a large extent, the number “3” or “three” _was searched with the word “omega.”
`
`The results are not supportive of the “merely descriptive” basis for rejection. For example,
`
`Applicants note the following:
`
`0 Attachment 1 uses the phrase “The three omegas,” with absolutely no context as to what
`
`“three” represents;
`
`0 Attachment 2 is a continuation of Attachment 1, with no reference to THE 3 OMEGAS;
`
`0 Attachment 3 is a continuation of Attachments 1 and 2, with no reference to THE 3
`
`OMEGAS;
`
`0 Attachment 4 is a continuation of Attachments 1, 2 and 3, with no reference to THE 3
`
`OMEGAS;‘
`
`0 Attachment 5 is from Applicants’ website which references Omega 3 and Omega 6 fatty
`
`acids, with no reference to THE 3 OMEGAS;
`
`4 This attachment does, however, allude to omega-3, omega-6 and omega 9 fatty acids.
`
`11
`
`

`
`0 Attachment 6 is a continuation of Attachment 5, with no reference to THE 3 OMEGAS;
`
`0 Attachment 7 uses the term “Omega-3,” with no reference to THE 3 OMEGAS;
`
`0 Attachment 8 references the term “omega-3,” “three experts and “three main forms [of
`
`omega-3],” with no reference to THE 3 OMEGAS;
`
`0 Attachment 9 is a continuation of Attachment 8, with no reference to THE 3 OMEGAS;
`
`0 Attachment 10 is a continuation of Attachments 8 and 9 and references “three grams,”
`
`with no reference to THE 3 OMEGAS;
`
`0 Attachment 11 references “Omegas,” “Omega—3s” and “three types of fats,” with no
`
`reference to THE 3 OMEGAS;
`
`0 Attachment 12 is a continuation of Attachment 11, with no reference to THE 3
`
`OMEGAS;
`
`0 Attachment 13 is a continuation of Attachments 11 and 12, with no reference to THE 3
`
`OMEGAS;
`
`0 Attachment 14 is a continuation of Attachments 1], 12 and 13, with no reference to THE
`
`3 OMEGAS;
`
`0 Attachment 15 is a continuation of Attachments 11 through 14, with no reference to THE
`
`3 OMEGAS;
`
`0 Attachment 16 is a continuation of Attachments 11 through 15, with no reference to THE
`
`3 OMEGAS; and
`
`I Attachment 17 is a continuation of Attachments 11 through 16, with no reference to THE
`
`3 OMEGAS.
`
`Conclusion
`
`For the reasons set forth above, Applicants submit that their THE 3 OMEGAS mark is not
`
`merely descriptive, but suggestive, and is entitled to registration.
`
`12
`
`

`
`The Board is therefore respectfully requested to reverse the Examining Attorney's decision
`
`refusing registration of Applicants’ Mark.
`
`Respectfully submitted,
`
`Agricultural Omega Solutions, LLC and
`Omega Valley Farmers, LLC
`By Their Attorneys
`
` Dated: June 21, 2013
`
`Josh S. Heino
`
`
`
`Patr k M. Bergin
`Dav s & Kuelthau, s.c.
`East Kilbourn Avenue, Suite 1400
`
`
`
`'
`
`ilwaukee, WI 53202
`'
`414.225.1452
`
`414.278.3652
`
`}'heino@dl<att0rneys.com
`pbergin@,dkattorneys.co1n
`
`N:\DOCS\83032'\000O5\l1526225
`
`

`
`
`
`Omega-7 Fatty Acids - The Essential Non-Essential Fatty
`Acids
`
`What is omega—7?
`
`Most of us have heard of ome-ga~3 essential fatty acids, and maybe o1nega—6
`
`essential fatty acids. There are also omega—9 fatty acids, which are not
`
`"essential," that is, you don't have to get them in your diet so you won't die,
`
`and there is yet another group of useful but non-essential fatty acids known as
`
`the omega—7's. Here are seven things you need to know about omega-7's and
`
`your health.
`
`1. Omega-7 fatty acids are a healthy form of trans- fat.
`
`Trans- fat gets a bad rap because some kinds of trans— fat increase
`
`cellular inflammation and irritate the linings of arteries. Omega—7 fatty
`
`acids like vaccenic {literally "cow") fatty acid found in dairy products is
`
`a trans— fat that helps your body overcome inflammation, if you don't
`
`eat too much of other fatty foods.
`
`2. Omega»? fatty acids are not found in non-fat foods.
`
`It may seem obvious, but you don't get your omega—7's in non—fat dairy
`
`products. Only dairy products made with whole milk or at least 2 per
`
`cent fat milk provide these fatty acids. Omega—7 fatty acids are in liquid
`
`milk, cheese, and yogurt.
`
`3. The omega-7 fatty acid in dairy products may actually lower
`
`cholesterol.
`
`Scientists at the University of Albert have found that feeding lab rats
`
`vaccenic acid for sixteen Weeks lowered total cholesterol, LDL
`
`cholesterol, and triglycerides. This is not, of course, the effect that you
`
`would expect by feeding yourself lots of cheese and butter.
`
`EXHIBIT D i
`
`

`
`4. The best vegetarian source of omega-7 fatty acids is sea buckthorn.
`
`"Sea buckthorn, despite its name, is not an ocean plant. The sea
`
`buckthorn is a plant that grows in high~salt conditions both along the
`
`ocean shoreline and in deserts, from western Europe to Mongolia. The
`
`berries are inedible unless they are "blotted," frozen to increase their
`
`sugar content, but they are a terrific source of vitamin C, containing 15
`
`times as much vitamin C as oranges. Sea buckthorn berries are also a
`
`rich source of omega—7 fatty acids used to make both nutritional
`
`supplements and skin care products.
`
`5. Macadamia nuts are also rich in omega—7 fatty acids.
`
`Macadamia nuts are rich in palmitoleic acid, an omega—7 fatty oil that
`
`provides the building blocks for the enzymes that control the burning of
`
`fat. Australian researchers have investigated palmitoleic acid as a
`
`treatment for obesity. Of course, you don't want just to eat lots of
`
`macadamia nuts to try to lose weight! Palmitoleic acid supplements are
`
`the appropriate weight loss tool.
`
`6. Too much omega—7 in the diet causes an unpleasant side effect.
`
`When omega»? fatty acids accumulate in the oily sebum that lubricates
`
`the skin, they are broken down into the chemical 2—noneal, which
`
`causes the phenomenon known as "old people smell." Frequent washing
`
`and specially formulated cosmetics eliminate the smell.
`
`‘7. You can get the benefits of omega-7's without the risk of old people
`
`smell by taking omega-7 supplements.
`
`Your body does not need omega—’7's to function. Certain, specific omegaf/‘s
`
`have desired health effects. Taking omega—7 supplements gives you the health
`
`benefits without causing accumulation of o1nega—'7's in your skin.
`
`And no matter what your age, ornega—7 supplements can provide essential
`
`health benefits, especially in weight loss and cholesterol control. Omega-7's in
`
`

`
`supplement form can be the non—essential fatty acid that is essential to your
`health.
`
`Selected References:
`
`0 Power, G.W., Cake, M.l-I. 8:. Newsholme EA. [1997} The influence of diet on the activity of
`
`camitine palrnitoyltransferase 1 toward a range of acyl COA esters. Lipids 32: 3.1w37 .
`
`Omega-zz Side Effects
`
`Does omega»? have any side effects?
`
`Omega—z Benefits
`
`What are the health benefits of Omega—'7?
`
`Read Our
`
`Guide
`
`Learn How
`
`To Choose
`a
`
`High
`Quality 85
`Safe
`
`Fish Oil
`
`Sugplement
`
`
`
`
`
`Related Articles
`
`o Omega—'7 Side Effect - The Problems You Can Encounter from Taking
`Too Much of the Wrong Omega—'7 Side Effects
`
`0 Omega-7 Benefit
`
`-~ Omega—7 Benefits — Could Consuming Fat Actually
`
`Help You Lose Weight?
`
`

`
`Bookmark or Share This! fwhatare these?)
`
`1
`
`.i..
`.1.
`
`JE
`
`

`
`.
`
`Our TOP 3 Recommended Fish Oil Brands
`
` ’~-,--..
`
`New Vitalig
`
`
`
`Fat Acids HubPriVac Polio ermsAdvertisin Contact UsSitema Ea
`
`© Copyright 2011, Fatty Acids Hub
`
`

`
`Effects of Fatty Acids on Reproduction in the Dairy Cow:
`'
`The Good and the Bad
`
`Helene V. Petit, Ph. D.
`_
`Dairy and Swine Research and Development Centre
`Agriculture and Agri—Food Canada
`P. O. Box 90, Lennoxville, QC JIM 1Z3
`Canada
`
`Introduction
`
`Recently, there has been a great deal of interest in feeding fat to dairy cows in
`order to increase energy density of the diet and improve reproduction. It is known that
`cows fed supplemental fat may experience improved energy balance and begin to cycle
`sooner because of enhanced follicular growth and development (Grummer and Carroll,
`1991). However, Lucy et al. (1992) suggested that it was fatty acids, and not the
`additional energy provided by the fatty acids, that stimulated ovarian fimction. Recently,
`new information has been published that demonstrates that the type of dietary fatty acids
`is important as individual fatty acids do not have the same effects on reproduction of the
`dairy cow.
`
`Fatty Acid Terminology
`
`A fatty acid molecule is shaped like a caterpillar with two different ends: a methyl
`group and a water-soluble end that is the carboxyl end." There ‘are '_different"_familieS—of
`"fatty acids in feed: _o_r'ne'ga-3, omega-6, omega-7, and oinega-.9.'_-The most common
`numbering system is called the omega system. This system numbers carbon atoms in
`sequence, starting from the methyl end. The other commonly used system, called the
`delta (d) system, starts at the acid end and numbers the carbon atoms in reverse direction.
`
`The omega-7 family of fatty acids is synthesized fi'om palmitic acid (C16:O) while
`the omega-9 fatty acid family is synthesized fi'om stearic acid (C1820) via oleic acid
`(C18: 1, Figure 1). These two families are not considered essential as they are produced in
`the body.
`
`The omega-3 and omega-6 fatty acids are essential because both are vital to
`health but cannot be made by our cells and must, therefore, be provided by foods.
`
`Linoleic acid (Cl 8:2) belongs to the omega-6 family while linolenic acid (C183)
`belongs to the omega-3 family (Figure 2). The system used to name fatty acids considers
`the number of carbons in the chain (e.g. 18 for linoleic acid), the number of double bonds
`in the chain (2 for linoleic acid) and where in the chain the first double bond is located
`from the methyl end (lst double bond between carbons 6 and 7 for linoleic acid): C18:2.
`
`EXHIBIT E
`
`

`
`Figure 1. Schematic pathway of omega-7 and omega-9 fatty acid synthesis.
`
`Ci-4:0
`
`C18:1
`
`I
`Palmitic Acid abr-
`C1620
`I
`Stearic Acid —I> Oleic Acid —>Omcga9
`C18:0
`
`Figure 2. Schematic pathway of omega-6 and omega—3 fatty acid synthesis.
`
`0mega—6 fatty acids
`
`Omega.-3 fatty acids
`
`C18:2n6 Linoleic acid
`
`Cl8:3n3 u~LinoIaic acid
`
`¢ -ta A6 Desaturase an- ‘
`
`Cl8:3n6 'y=~I;.inolenic acid
`
`C18:4n3 Stearidonic acid
`
`‘ «T Elongase an- *
`
`C20:3n6 Dihomo-7-Linolenic acid
`
`C20:4n3 Eioosateuaenoic acid
`
`J, «T A5 Desaturase ——e- {,
`C20:4n6 Arachidnnic amid
`'
`' C20:5n3 Eicosapentaenoic acid
`
`

`
`‘Sources of Fatty Acids
`
`The main sources of short chain fatty acids are cottonseed and palm oils. All
`sources of fat contain long chain fatty acids. The main sources of linolenic acid
`(C18:3n3) are flaxseed, hemp, canola, soybean, nuts and dark green forages. Ryegrass
`silage contains as much as 60% of Iinolenic acid as a percentage of total fatty acids
`(Dewhurst and King, 1998), which would encourage high forage systems to increase
`dietary linolenic acid content. Omega—3 fatty acids are found also in cold water and salt
`water fish (salmon,
`trout, mackerel, sardines). The main sources of Iinoleic acid
`(C18:2n6) are sunflower seed, safflower, hemp, soybean, nuts, pumpkin seeds, sesame
`seeds and flaxseed. Gamma-linolenic acid (Cl8:3n6) is found in evening prirnose oil,
`grape seeds and borage. Dihomogamma-linolenic acid (C20:3n6) is found in maternal
`milk while arachidonic acid (C20:-4n6) occurs mainly in meat and animal products. Oleic
`acid (C1821) is found in olive, almond, avocado, peanut, pecan, cashew, macadamia nut
`and butter. Omega 7 in the form of palrnitoleic acid (C16:l) is found in tropical oils
`(coconut, palm). Composition in C18 fatty acids of some edible vegetable oils is
`reported in Table 1.
`
`Adapted from Erasmus (1993).
`
`Fatty Acids and Fertility
`
`Supplementary fats are likely to affect fertility because fatty acids are the
`precursors both of prostaglandins (PG) and, via cholesterol, the steroid hormones. In
`general, feeding supplemental fat such as calcium soaps of long chain fatty acids, fish
`meal, and tallow increases conception rates. However, a lowered conception rate at first
`service has been reported when there was a paralleled increase in milk production (range
`
`

`
`of 2.2 to 4.5 kg/d). Thatcher and Staples (2000) wrote an excellent review on the subject.
`There are two main families of essential fatty acids, omega-3 and omega-6 fatty acids,
`that could affect fertility. The main source of omega-6 fatty acids is dietary linoleic acid
`(Cl8:2n-6) and this is converted to arachidonic acid (C20:4n-6), which inter alia is the
`precursor of the dienoic (2-series) PG, such as PGF;;_.,. The same elongase and desaturase
`enzymes also convert the main dietary omega-3 fatty acids (oi-linolenic acid; C18:3n-3)
`-to eicosapentaenoie acid (EPA; C20:5n-3), the precursor of the trienoic (3-series) PG,
`such as PGF3.;, (Abayasekara and Wathes, 1999). Competition between omega-3 and
`omega-6 precursors for desaturation and elongation as well as at the site of PG synthetase
`means that increasing the Supply of omega-3 fatty acids will decrease production of
`dienoic PG (Barnouin and Chassagne, 1991). In many cases the trienoic PG have lower
`biological activity than the corresponding dienoic PG (Fly and Johnston, 1990) and this
`may directly affect aspects of fertility. For example, treatments that reduce ovarian and
`endometrial synthesis of PGF2a, at the expense of PGF3.,, may contribute to a reduction
`in embryonic mortality (Mattos er al., 2000). There is some evidence for different effects
`of oi-linolenic acid and the omega-3 fatty acids from fish oil (EPA and docosahexaenoic
`acid (DHA), C22:6n-3) on eicosanoid (interleukin) synthesis, perhaps because of
`differences in the way in which these fatty acids incorporate into cell membranes (Wu et
`al., 1996).
`
`Supplementary fats can also reduce the total synthesis of PG by affecting the
`activity of PG synthase (Thatcher et al., 1995). Diets rich in linoleic acid (C18:2)
`increase arachidonic acid concentration (C20:4) in tissues and diets rich in linolenic acid
`(C18:3) increase concentration of eicosapentaenoic acid (C20:5) (Béréziat, 1978).
`Moreover, eicosapentaenoic acid (C20:5) is a competitive inhibitor of the enzyme
`complex involved in the synthesis of prostaglandins from arachidonic acid (C20:4) (Leat
`and Northrop, 1979; Holman, 1986). Therefore, this would suggest that a diet with a low
`lirioleic to linolenic acid ratio (Cl8:2:C18:3, omega-6:omega-3) could decrease
`prostaglandin secretion or prostagiandin activity as suggested by Barnouin and
`Chassagne (1991), which would thus have important effects on reproduction and
`immunity in the dairy cow.
`
`Prostagladins Synthesis
`
`There are two main pathways (Figure 3) used to synthesize PG: one is used by
`most dietary fat (e.g. corn and soybean, sources of omega-6 fatty acids) and leads to
`series 1 and 2 PG while the other one is more specific to fish products and flax (sources
`of omega-3 fatty acids) and leads to series 3 PG. Thus, depending on the pathway used
`for PG synthesis, the type and role of the resulting PG will differ. PG of series 2 are
`"important at calving; they increase platelet agglutination and blood clot formation, they
`increase salt retention in kidneys, water retention, and blood pressure. PG of series 2 aiso
`cause inflammation, which leads to their role of “bad guys” among the different PG
`SBHCS.
`
`

`
`Figure 3. Metabolic pathway of series 1,2 and 3 prostaglandins.
`
`a ega—6 may adds
`
`
`o.i.ega;s ratiy ids
`
`
`
`C18:2n6 Lincleic acid
`
`C18:3r13 or-Linoieic acid
`
`C18:3n6 'g~Lino1cnic acid
`
`CI8:4n3 Stearidonic acid
`
`C20:3n6 Diliomo-ye-Linclenic acid
`# C Series 1
`Proshghmdim
`C20:4n6Aracl1idcnic acid
`cyclooxygenase If
`C
`pmgtaglandins H,
`Parrrsnaarm
`
`Saw: 2
`
`C20:4n3 Eiccsatetracncic acid
`V‘
`C20:5n3 Eicosapentacnoic acid
`
`C /‘Zn:-ostaglandhi synthasc
`
`Series 3
`
`improve the immune sytem of T cells, prevent platelet
`1
`PG of series
`agglutination and heart attack, contribute to remove the excess of Na and water in
`kidneys, decrease the inflarnrnatory responseand contribute in controling arthritis and
`decreasing cholesterol production. PG of the series" 3 have a very weak platelet
`agglutination power and they prevent fabrication of PG of the series 2; they also prevent
`heart attack, water retention, and inflammation. PG of the series 1 and 3 are thus
`considered as “good guys” contrary to those of the series 2. In fact, our preliminary
`results (Gagnon er al., 2000) showed that some immune parameters were affected by the
`type of dietary fatty acids at the time of embryo implantation.
`Some polyunsaturated fatty acids (PUFA) can serve as a substrate for the
`synthesis of PGFM. These include cis-linoleic acid (Cl8:2) that is commonly found in
`natural fat sources. It can be desaturated and elongated to form arachidonic acid which
`serves as an immediate percursor for the series 2 PG of which PGF20, is a key member.
`Key regulatory enzymes
`for
`these conversions
`include A six desaturase and
`cyclooxygenase. These same fatty acids also can inhibit PG synthesis by competitive
`inhibition with these key enzymes. Linoleic acid has been shown to be an inhibitor of PG
`synthesis that is produced by the endometrium in response to the presence of a conceptus
`in order to perserve the integrity of the conceptus (Thatcher et al., 1994). Other fatty
`acids besides linoleic acid can play inhibitory roles. EPA and docosahexanoic acid
`(C22:6) have been shown to inhibit cyclooxygenase activity, which is an enzyme
`involved in the synthesis of PGF2o,+.
`
`Fatty Acids, Cholesterol, and Progesterone
`Cholesterol serves as a precursor for the synthesis of progesterone by ovarian
`luteal cells.
`Secretion of prog

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket